Cargando…

Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis

Detalles Bibliográficos
Autor principal:	Paik, Yong-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694729/ https://www.ncbi.nlm.nih.gov/pubmed/26696027 http://dx.doi.org/10.5009/gnl15576

Ejemplares similares

Doxazosin and Carvedilol Treatment Improves Hepatic Regeneration in a Hamster Model of Cirrhosis
por: Serna-Salas, Sandra Alejandra, et al.
Publicado: (2018)

Protective Effect of Curcumin against Doxazosin- and Carvedilol-Induced Oxidative Stress in HepG2 Cells
por: Medina-Pizaño, Mariana Yazmin, et al.
Publicado: (2022)

The antihypertension drug doxazosin suppresses JAK/STATs phosphorylation and enhances the effects of IFN-α/γ-induced apoptosis
por: Park, Mi Sun, et al.
Publicado: (2014)

Comments on ALLHAT and doxazosin
por: Krakoff, Lawrence R
Publicado: (2001)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
por: Tian, Xiaopeng, et al.
Publicado: (2017)

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
por: Piller, Linda B, et al.
Publicado: (2002)

The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression
por: Park, Mi Sun, et al.
Publicado: (2014)

Determination of Doxazosin Mesylate in Tablets by RP-HPLC
por: Dhanya, B., et al.
Publicado: (2011)

Doxazosin in the treatment of benign prostatic hypertrophy: an update
por: Wilt, Timothy J, et al.
Publicado: (2006)

Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
por: Wu, Ying, et al.
Publicado: (2019)

Unexpected bradycardia after a first dose of doxazosin
por: Pigot, James Edward, et al.
Publicado: (2022)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Alcoholic Hepatitis and Intestinal Barrier Breakdown: A Theoretical Reappraisal Based on Pentoxifylline's Action
por: Assimakopoulos, Stelios F., et al.
Publicado: (2009)

Treating nightmares in PTSD with doxazosin: a report of three cases
por: Calegaro, Vitor Crestani, et al.
Publicado: (2019)

Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway
por: Xiu, Ai-Yuan, et al.
Publicado: (2021)

The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof
por: Veldhuizen, Gregory P., et al.
Publicado: (2021)

Adenoviral-bone morphogenetic protein-7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model
por: Cervantes-Garcia, Daniel, et al.
Publicado: (2017)

E.C.T.: A NEED OF REAPPRAISAL
por: Agarwal, A.K.
Publicado: (1990)

The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis
por: Park, Suhyun, et al.
Publicado: (2019)

Doxazosin for the treatment of nightmare disorder: A diary-based case study
por: Pallesen, Ståle, et al.
Publicado: (2020)

Determination of Alkyl Methanesulfonates in Doxazosin Mesylate by Gas Chromatography-mass Spectrometer
por: Sitaram, C., et al.
Publicado: (2011)

The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats
por: Haile, Colin N., et al.
Publicado: (2012)

SAT-211 Is Doxazosin the Right Choice for Preoperative Management of Pheochromocytoma in Pregnancy?
por: Bustos, Mario, et al.
Publicado: (2020)

Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia
por: Ohsfeldt, Robert L., et al.
Publicado: (2004)

The ubiquitous interleukin-6: a time for reappraisal
por: Fisman, Enrique Z, et al.
Publicado: (2010)

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
por: Kim, Seongjae, et al.
Publicado: (2023)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion
por: Muñoz-Ortega, Martin Humberto, et al.
Publicado: (2016)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk
por: Versmissen, Jorie, et al.
Publicado: (2016)

Mechanism of carvedilol induced action potential and calcium alternans
por: Martinez-Hernandez, Elizabeth, et al.
Publicado: (2022)

A case of doxazosin-induced acute coronary syndrome in a patient with myocardial bridging
por: Cerit, Levent, et al.
Publicado: (2016)

Implementation science: a reappraisal of our journal mission and scope
por: Foy, Robbie, et al.
Publicado: (2015)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
por: Danysz, Wojciech, et al.
Publicado: (2021)

R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
por: Gavras, Irene, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_fsu68h1a3k0rqlk3gcdehkc5df